RSS

diabetes

This week the team sits down to discuss the current thinking around diabetes and how healthtech can help. Dave explains what nudge theory is and why everyone with a Fitbit is inadvertently being influenced by it. Read more

News

Reece Armstrong examines the story behind a Cambridge-based biotech’s potential treatment for diabetes. Read more

News

Researchers from the University of Southern California (USC) have launched a global scientific effort to find the next diabetes drug by creating a comprehensive model of a cell that is central to the disease. Read more

News

Eli Lilly and digital health company Rimidi, have teamed up to create personalised solutions for people that use insulin to manage diabetes. Read more

News

The US Food and Drug Administration (FDA) has approved Sanofi’s short-acting insulin (Admelog — insulin lispro injection) as a ‘follow on’ product to treat diabetes. Read more

News

Clinical-stage company, Sernova has received a notice of allowance from the US Food and Drug Administration (FDA) for its investigational new drug (IND), with which it will initiate a clinical trial of its Cell Pouch System (CPS) in the US. Read more

News

Plant-based ingredients company, Roquette, has opened new offices and an innovation centre in Singapore, which will focus on food, nutrition and pharma to better address eating habits and health concerns of Asian consumers. Read more

News

Global healthcare company, Novo Nordisk, has revealed that the US Food and Drug Administration (FDA) has approved its fast-acting mealtime insulin, Fiasp, for the improvement of glycaemic control in adults with diabetes. Read more

Technology

Global healthcare company, Novo Nordisk, and digital platform and data analytics company, Glooko, have launched an integrated app to help people manage diabetes called Cornerstones4Care (C4C). Read more

Technology

Cold-chain packaging specialist, Peli BioThermal, celebrates the return of two cyclists who have been on a global bike ride for the past 12 months to raise awareness of diabetes. Read more

News

Global pharmaceutical company Roche has acquired a mobile diabetes platform to bolster its digital health services. Read more

News

Sanofi and Regeneron Pharmaceuticals have announced positive results from two Phase IIIb/IV ODYSSEY-DM trials evaluating Praluent (alirocumab) in patients with diabetes and hypercholesterolemia. Read more

News

A widely used diabetes medication could help people with a common inherited form of autism, research shows. Read more

News

The FDA has issued a complete response letter denying Merck’s application to include cardiovascular information on its drug labels for its diabetes drugs, Januvia and Janumet. Read more

News

Multinational pharmaceutical firm Novo Nordisk has announced that it will collaborate with remote patient monitoring provider Glooko. Read more

News

With €134M ($140M) backing from the Bill & Melinda Gates Foundation, Intarcia Therapeutics is to develop its Medici drug delivery system that will reduce dosing frequency for HIV prevention medication. Read more

News

Arecor is a company working on the next generation in diabetes care. CEO Sarah Howell sat down with EPM to talk about the future of the disease Read more

News

New collaboration between Sanofi and Verily Life Sciences aims to help people with diabetes live full, healthy lives. Read more

News

Martindale Pharma’s Noyada, a medication that targets heart conditions in children, has been approved for early access in France due to an ATU de’ Cohorte (Temporary Authositaion for Use) programme Read more

News

With Valentines Day over and Easter fast-approaching, the second month of the year is already drawing to a close. We take a look at our most read stories from the last month. Two down and ten more to go… Read more

Opinion